Diana Marszalek 28 Sep 2023 // 12:30AM GMT
SKILLMAN, NJ — Roughly a month after its official separation from Johnson & Johnson, Kenvue is rolling out a slate of new agency partners including Golin, M Booth Health and Zeno, PRovoke Media has learned.
“Golin, M Booth Health and Zeno Group have each been awarded projects within our North America product portfolio to help us drive a meaningful impact on the lives of the consumers we serve every day,” a Kenvue spokesperson told PRovoke Media. Specifically, Golin will work on Neutrogena, M Booth Health on Aveeno and Zeno Group on Johnson’s, the company said.
Neither Kenvue nor the agencies would elaborate on the details of the partnerships or the process leading up to them.
Sources, however, say the assignments are relatively new resulting from a selection process earlier this year.
All three of the agencies have histories of working with J&J in various capacities before the pharmaceutical giant spun off its consumer health division into an independent company.
Golin, for instance, has handled PR for both Neutrogena and Aveeno since it won the business in a competitive review in 2020, when it displaced the beauty agency RPR Public relations.
J&J also has been a longtime client of M Booth Health sister agency M Booth, whose recent projects include advising Kenvue on its strategy and launch.
Zeno’s relationship with J&J dates back to at least 2014, when the agency started handling consumer PR for Tylenol.
Shop PR and Marina Maher Communications have also been among J&J’s PR agencies. In 2018, both Omnicom and WPP created dedicated teams dedicated to the networks' J&J business, including advertising, called Velocity and Neighborhood respectively. These were disbanded the following year.
Kenvue, which made its final separation from J&J in August, houses J&J’s portfolio of consumer health brands including Aveeno, Band-Aid, Johnson’s, Listerine, Neutrogena and Tylenol.
Executives initiated the spinoff in 2019 so that J&J can focus its efforts on medical innovation and technology and pharmaceuticals.